Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Anticancer Research
|
July 3, 2017
Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC)
Axel Wein, Juergen Siebler, Kerstin Wolff, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
March 2, 2010
Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV)
Sandra Roehrig, Axel Wein, Heinz Albrecht, et al.
Case Reports in Oncological Medicine
|
May 22, 2013
Granulomatous lung disease requiring mechanical ventilation induced by a single application of oxaliplatin-based chemotherapy for colorectal cancer: a case report
Dane Wildner, Frank Boxberger, Axel Wein, et al.
Anti-Cancer Drugs
|
January 7, 2009
Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial
Kerstin Wolff, Axel Wein, Udo Reulbach, et al.
Case Reports in Oncology
|
September 24, 2011
Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV)
Sandra Roehrig, Axel Wein, Heinz Albrecht, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
October 28, 2008
The Stockholm classification of stillbirth
Ingela Hulthén Varli, Karin Petersson, Roger Bottinga, et al.
Case Reports in Oncology
|
August 5, 2016
Successful Multidisciplinary Treatment with Secondary Metastatic Liver Resection after Downsizing by Palliative Second-Line Treatment of Colorectal Cancer: A Curative Option
Axel Wein, Jürgen Siebler, Ruediger Goertz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
April 29, 2011
Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing
Kathrin Koucky, Axel Wein, Peter C Konturek, et al.
Oncology
|
October 20, 2021
A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results
Axel Wein, Robert Stoehr, Stephan Kersting, et al.
Cancers
|
December 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center
Lars Tögel, Christoph Schubart, Sebastian Lettmaier, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Anticancer Research
|
July 3, 2017
Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC)
Axel Wein, Juergen Siebler, Kerstin Wolff, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
March 2, 2010
Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV)
Sandra Roehrig, Axel Wein, Heinz Albrecht, et al.
Case Reports in Oncological Medicine
|
May 22, 2013
Granulomatous lung disease requiring mechanical ventilation induced by a single application of oxaliplatin-based chemotherapy for colorectal cancer: a case report
Dane Wildner, Frank Boxberger, Axel Wein, et al.
Anti-Cancer Drugs
|
January 7, 2009
Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial
Kerstin Wolff, Axel Wein, Udo Reulbach, et al.
Case Reports in Oncology
|
September 24, 2011
Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV)
Sandra Roehrig, Axel Wein, Heinz Albrecht, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
October 28, 2008
The Stockholm classification of stillbirth
Ingela Hulthén Varli, Karin Petersson, Roger Bottinga, et al.
Case Reports in Oncology
|
August 5, 2016
Successful Multidisciplinary Treatment with Secondary Metastatic Liver Resection after Downsizing by Palliative Second-Line Treatment of Colorectal Cancer: A Curative Option
Axel Wein, Jürgen Siebler, Ruediger Goertz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
April 29, 2011
Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing
Kathrin Koucky, Axel Wein, Peter C Konturek, et al.
Oncology
|
October 20, 2021
A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results
Axel Wein, Robert Stoehr, Stephan Kersting, et al.
Cancers
|
December 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center
Lars Tögel, Christoph Schubart, Sebastian Lettmaier, et al.
Page
of 3